119 related articles for article (PubMed ID: 37003518)
1. Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancer.
Jain S; Parimelazhagan Santhi P; Vinod R; Afrin Ruma S; Huhtinen K; Pettersson K; Sundfeldt K; Leivo J; Gidwani K
Clin Chim Acta; 2023 Mar; 543():117323. PubMed ID: 37003518
[TBL] [Abstract][Full Text] [Related]
2. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer.
Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA; Terävä J; Huhtinen K; Leivo J; Kristjansdottir B; Pettersson K; Sundfeldt K; Gidwani K
Int J Cancer; 2022 Oct; 151(7):1175-1184. PubMed ID: 35531590
[TBL] [Abstract][Full Text] [Related]
4. Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3.
Ekman M; Salminen T; Raiko K; Soukka T; Gidwani K; Martiskainen I
Anal Bioanal Chem; 2024 May; 416(13):3251-3260. PubMed ID: 38584178
[TBL] [Abstract][Full Text] [Related]
5. Early inflammatory response in epithelial ovarian tumor cyst fluids.
Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
[TBL] [Abstract][Full Text] [Related]
6. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Aided Detection of Colorectal Cancer-Associated Glycoconjugates of Extracellular Vesicles in Human Serum.
Vinod R; Mahran R; Routila E; Leivo J; Pettersson K; Gidwani K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638669
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
9. Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling.
Lee J; Lee J; Choi C; Kim JH
Sci Rep; 2019 Feb; 9(1):2793. PubMed ID: 30808960
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study.
Mahyuddin AP; Liu L; Zhao C; Kothandaraman N; Salto-Tellez M; Pang B; Lim D; Annalamai L; Chan J; Lim T; Biswas A; Rice G; Razvi K; Choolani M
BJOG; 2018 Mar; 125(4):421-431. PubMed ID: 28755436
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.
Wieczorek M; Braicu EI; Oliveira-Ferrer L; Sehouli J; Blanchard V
Front Immunol; 2020; 11():654. PubMed ID: 32477323
[TBL] [Abstract][Full Text] [Related]
12. Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.
Ning L; Lang J; Wu L
BMC Cancer; 2022 Jan; 22(1):6. PubMed ID: 34980005
[TBL] [Abstract][Full Text] [Related]
13. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
15. Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses.
Salminen L; Nadeem N; Rolfsen AL; Dørum A; Laajala TD; Grènman S; Hietanen S; Heinosalo T; Perheentupa A; Poutanen M; Bolstad N; Carpén O; Lamminmäki U; Pettersson K; Gidwani K; Hynninen J; Huhtinen K
J Appl Lab Med; 2020 Mar; 5(2):263-272. PubMed ID: 32445385
[TBL] [Abstract][Full Text] [Related]
16. A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.
Gidwani K; Huhtinen K; Kekki H; van Vliet S; Hynninen J; Koivuviita N; Perheentupa A; Poutanen M; Auranen A; Grenman S; Lamminmäki U; Carpen O; van Kooyk Y; Pettersson K
Clin Chem; 2016 Oct; 62(10):1390-400. PubMed ID: 27540033
[TBL] [Abstract][Full Text] [Related]
17. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
Ruhaak LR; Kim K; Stroble C; Taylor SL; Hong Q; Miyamoto S; Lebrilla CB; Leiserowitz G
J Proteome Res; 2016 Mar; 15(3):1002-10. PubMed ID: 26813784
[TBL] [Abstract][Full Text] [Related]
18. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
Kristjansdottir B; Levan K; Partheen K; Sundfeldt K
Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
